Margaret Gleeson - Berkeley Heights NJ, US Gary McGeorge - Franklin Park NJ, US Huiping Zhang - Belle Mead NJ, US Mary Malley - Lawrenceville NJ, US John DiMarco - East Brunswick NJ, US Denette Murphy - Princeton NJ, US Xiaotian Yin - Plainsboro NJ, US Steven Fabian - Barnegat NJ, US Jasmine Gupta - Monmouth Junction NJ, US
International Classification:
C07D 471/02 A61K 31/4745
US Classification:
514303000, 546118000
Abstract:
The instant invention provides crystalline forms of 1-(3-chlorophenyl)-7-oxo-6-[4-(2-oxo-1 (2H)pyridinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide and its solvates thereof; processes for the production of such crystalline forms; pharmaceutical compositions comprising such crystalline forms; and methods of treating thromboembolic disorders with such crystalline forms or such pharmaceutical compositions.
Bristol-Myers Squibb since Aug 2007
Research Scientist
Education:
University of the Sciences in Philadelphia 2007 - 2013
Ph.D., Pharmaceutics
University of Louisiana at Monroe 2000 - 2002
Master of Science (M.S.), Chemistry
University of Mumbai 1994 - 1998
Bachelor of Pharmacy (B.Pharm.), Pharmaceutical Sciences
MVLU College 1992 - 1994
HSC, Science
Skills:
Pharmaceutics R&D Formulation Pharmaceutical Industry Drug Development Project Planning Preformulation Drug Delivery Molecular Modeling Molecular Dynamics GastroPlus Biopharmaceutics Product Development Outsourcing CMC development IND Capsule Development Clinical Manufacturing Granulation Amorphous dosage forms Kinetic Modeling Solubilized dosage forms GLP GMP Project Management CMC Drug Discovery